Otsuka Yuki, Nakano Yasuhiro, Hagiya Hideharu, Tokumasu Kazuki, Otsuka Fumio
Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, JPN.
Cureus. 2022 Jan 12;14(1):e21160. doi: 10.7759/cureus.21160. eCollection 2022 Jan.
Herein, we report a remarkable case of post-coronavirus disease 2019 (COVID-19) diffuse alopecia that gradually improved and recovered, and the hair volume returned approximately to the pre-infection level, seven months after the patient's first diagnosis of COVID-19. Approximately 20% of patients with COVID-19 develop alopecia a few months after the acute infection phase. Telogen effluvium is the major type of COVID-19 sequela secondary to physical or psychological distress. It is reversible and is expected to improve without any treatment, and it can be addressed by explaining to the patients their conditions, sharing medical information, and eliminating psychophysical stress by managing systemic complications.
在此,我们报告一例2019冠状病毒病(COVID-19)后弥漫性脱发的显著病例,该病例逐渐改善并康复,患者首次诊断为COVID-19七个月后,发量大致恢复到感染前水平。约20%的COVID-19患者在急性感染期后的几个月会出现脱发。休止期脱发是COVID-19继发于身体或心理应激的主要后遗症类型。它是可逆的,预计无需任何治疗即可改善,可通过向患者解释其病情、分享医疗信息以及通过处理全身并发症消除身心压力来解决。